InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,460.48
(
-0.41%
)
US TECH 100
19,181.60
(
-0.43%
)
Dow Jones
39,118.86
(
-0.12%
)
Brent Oil
84.85
(
0.00%
)
Bitcoin
60,846.78
(
0.89%
)
Post# of 252428
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

mcbio

Send PM Follow Ignore
Followers 69
Posts 6152
Boards Moderated 0
Alias Born 11/26/2008

mcbio

Re: DewDiligence post# 202472

Friday, 07/08/2016 1:21:59 PM

Friday, July 08, 2016 1:21:59 PM

Post# of 252428

What are you insuring against, exactly? If you pull the switch and thereby deactivate the immunotherapy, the patient will presumably die from the underlying disease. (It’s not realistic to think that such a patient could be switched to a different curative therapy.)

You'd be insuring against a safety event that could harm or kill the patient. Yes, once the drug switch is activated, I'd imagine there would be a switch to a non-CAR-T treatment. Why is that not realistic IYO?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up